We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+26.16%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$11.4B
AUM Growth
+$1.76B
Cap. Flow
-$330M
Cap. Flow %
-2.89%
Top 10 Hldgs %
18.38%
Holding
1,151
New
138
Increased
341
Reduced
503
Closed
146

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$32.1M
2
INTC icon
Intel
INTC
+$28.7M
3
GILD icon
Gilead Sciences
GILD
+$27.7M
4
APA icon
APA Corp
APA
+$27.5M
5
COST icon
Costco
COST
+$25.1M

Sector Composition

Rank Sector Weight
1 Technology 26.64%
2 Healthcare 14.08%
3 Consumer Discretionary 13.88%
4 Financials 13.05%
5 Industrials 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLD
776
DELISTED
TopBuild
BLD
$768K 0.01%
4,170
-1,607
-28% -$284K
MRAM icon
777
Everspin Technologies
MRAM
$339M
$763K 0.01%
165,791
+79,172
+91% +$480K
CARE icon
778
Carter Bankshares
CARE
$756M
$762K 0.01%
71,083
-5,188
-7% -$44.1K
RCKY icon
779
Rocky Brands
RCKY
$366M
$762K 0.01%
27,155
+325
+1% +$9.26K
CSLT
780
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$762K 0.01%
586,474
+60,448
+11% +$68K
CMI icon
781
Cummins
CMI
$87.3B
$760K 0.01%
3,348
+1,521
+83% +$342K
INOV
782
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$759K 0.01%
+41,774
New +$892K
CSTR
783
DELISTED
CapStar Financial Holdings, Inc
CSTR
$755K 0.01%
51,213
-2,301
-4% -$27.7K
CNX icon
784
CNX Resources
CNX
$4.9B
$752K 0.01%
69,657
+23,230
+50% +$234K
SWTX
785
DELISTED
SpringWorks Therapeutics
SWTX
$750K 0.01%
10,339
-1,189
-10% -$76.5K
LJPC
786
DELISTED
La Jolla Pharmaceutical Company
LJPC
$750K 0.01%
193,398
+38,748
+25% +$166K
ACOR
787
DELISTED
Acorda Therapeutics
ACOR
$745K 0.01%
8,996
+1,619
+22% +$149K
GOLD
788
Gold.com Inc
GOLD
$1.22B
$742K 0.01%
+57,852
New +$905K
AGNT
789
AGNT Inc
AGNT
$641M
$735K 0.01%
+23,304
New +$643K
NAVI icon
790
Navient
NAVI
$794M
$733K 0.01%
+74,686
New +$709K
SLCA
791
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$732K 0.01%
+104,228
New +$453K
CHE icon
792
Chemed
CHE
$7.1B
$730K 0.01%
1,370
+648
+90% +$318K
USAK
793
DELISTED
USA Truck Inc
USAK
$729K 0.01%
81,651
+62,104
+318% +$581K
PD icon
794
PagerDuty
PD
$800M
$722K 0.01%
17,319
-32,212
-65% -$1.1M
EW icon
795
Edwards Lifesciences
EW
$50B
$721K 0.01%
7,904
-70,229
-90% -$5.83M
CDAK
796
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$715K 0.01%
+22,129
New +$293K
AVAV icon
797
AeroVironment
AVAV
$7.42B
$714K 0.01%
8,218
+422
+5% +$33.9K
NTST
798
NETSTREIT Corp
NTST
$2.1B
$712K 0.01%
+36,514
New +$675K
BXC icon
799
BlueLinx
BXC
$416M
$705K 0.01%
24,096
+2,015
+9% +$51.5K
JNCE
800
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$705K 0.01%
100,743
-82,094
-45% -$639K

Similar funds

Jacobs Levy Equity Management's Q4 2020 Portfolio in Review

As of Q4 2020, Jacobs Levy Equity Management held 1,151 positions worth $11.4B, up 18% from $9.65B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Jacobs Levy Equity Management's Q4 2020 filing shows 138 new, 341 increased, 503 reduced and 146 closed positions. Its largest new stake was DexCom: 229,736 shares worth $21.2M. The largest sale was Optimum Communications Inc, an estimated $41M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q4 2020 buy was DexCom: 229,736 shares worth $21.2M.
  • Jacobs Levy Equity Management added most to Amazon in Q4 2020, an estimated $32.1M increase.
  • Jacobs Levy Equity Management's biggest Q4 2020 reduction was Qualcomm, cutting an estimated $33.6M.
  • Jacobs Levy Equity Management fully exited Optimum Communications Inc in Q4 2020, selling an estimated $41M.
  • Jacobs Levy Equity Management's ten largest holdings make up 18% of its $11.4B portfolio in Q4 2020.
  • Jacobs Levy Equity Management opened 138 new positions and closed 146 in Q4 2020.
  • Jacobs Levy Equity Management's portfolio value rose 18% quarter-over-quarter to $11.4B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2020, filed 16 Feb 2021.